Global Androstenedione Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Androstenedione market size is predicted to grow from US$ 207 million in 2025 to US$ 246 million in 2031; it is expected to grow at a CAGR of 2.9% from 2025 to 2031.
Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.
Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.
Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.
In the report, the data bases on androstenedione and androstadienedione.
Androstenedione production is concentrated relatively. Currently, there are several producing companies in the world androstenedione industry. The main market players are BIOVET, Indo Phyto Chemicals, Sito Bio, Goto Pharmaceutical, Tianjin King York and Jiufu. Tianjin King York is the leader in the global market, with about 16% market shares.
China is the largest production region and the share reached 77.68% in 2015. The shares of Europe, India and Asia Other were 11.51%, 2.58% and 2.79%.
LP Information, Inc. (LPI) ' newest research report, the “Androstenedione Industry Forecast” looks at past sales and reviews total world Androstenedione sales in 2024, providing a comprehensive analysis by region and market sector of projected Androstenedione sales for 2025 through 2031. With Androstenedione sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Androstenedione industry.
This Insight Report provides a comprehensive analysis of the global Androstenedione landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Androstenedione portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Androstenedione market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Androstenedione and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Androstenedione.
This report presents a comprehensive overview, market shares, and growth opportunities of Androstenedione market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Androstenedione market?
What factors are driving Androstenedione market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Androstenedione market opportunities vary by end market size?
How does Androstenedione break out by Type, by Application?
The global Androstenedione market size is predicted to grow from US$ 207 million in 2025 to US$ 246 million in 2031; it is expected to grow at a CAGR of 2.9% from 2025 to 2031.
Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.
Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.
Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.
In the report, the data bases on androstenedione and androstadienedione.
Androstenedione production is concentrated relatively. Currently, there are several producing companies in the world androstenedione industry. The main market players are BIOVET, Indo Phyto Chemicals, Sito Bio, Goto Pharmaceutical, Tianjin King York and Jiufu. Tianjin King York is the leader in the global market, with about 16% market shares.
China is the largest production region and the share reached 77.68% in 2015. The shares of Europe, India and Asia Other were 11.51%, 2.58% and 2.79%.
LP Information, Inc. (LPI) ' newest research report, the “Androstenedione Industry Forecast” looks at past sales and reviews total world Androstenedione sales in 2024, providing a comprehensive analysis by region and market sector of projected Androstenedione sales for 2025 through 2031. With Androstenedione sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Androstenedione industry.
This Insight Report provides a comprehensive analysis of the global Androstenedione landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Androstenedione portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Androstenedione market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Androstenedione and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Androstenedione.
This report presents a comprehensive overview, market shares, and growth opportunities of Androstenedione market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Androstenedione
- Androstadienedione
- Arthritis Pharmaceuticals
- Fertility Control Pharmaceuticals
- Infectious Inflammation Pharmaceuticals
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BIOVET
- Indo Phyto Chemicals
- Sito Bio
- Goto Pharmaceutical
- Tianjin King York
- Jiufu
- Yongning Pharma
- Jiangxi Hongyuan Pharmaceutical
- Kaizon
- Xi’an Gaoyuan Bio-Chem
- Dongyao Pharmaceutical
- Huazhong Pharmaceutical
- Darui
- Danjiangkou Danao
- Dahua Pharmaceutical
What is the 10-year outlook for the global Androstenedione market?
What factors are driving Androstenedione market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Androstenedione market opportunities vary by end market size?
How does Androstenedione break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Androstenedione Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Androstenedione by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Androstenedione by Country/Region, 2020, 2024 & 2031
2.2 Androstenedione Segment by Type
2.2.1 Androstenedione
2.2.2 Androstadienedione
2.3 Androstenedione Sales by Type
2.3.1 Global Androstenedione Sales Market Share by Type (2020-2025)
2.3.2 Global Androstenedione Revenue and Market Share by Type (2020-2025)
2.3.3 Global Androstenedione Sale Price by Type (2020-2025)
2.4 Androstenedione Segment by Application
2.4.1 Arthritis Pharmaceuticals
2.4.2 Fertility Control Pharmaceuticals
2.4.3 Infectious Inflammation Pharmaceuticals
2.4.4 Others
2.5 Androstenedione Sales by Application
2.5.1 Global Androstenedione Sale Market Share by Application (2020-2025)
2.5.2 Global Androstenedione Revenue and Market Share by Application (2020-2025)
2.5.3 Global Androstenedione Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Androstenedione Breakdown Data by Company
3.1.1 Global Androstenedione Annual Sales by Company (2020-2025)
3.1.2 Global Androstenedione Sales Market Share by Company (2020-2025)
3.2 Global Androstenedione Annual Revenue by Company (2020-2025)
3.2.1 Global Androstenedione Revenue by Company (2020-2025)
3.2.2 Global Androstenedione Revenue Market Share by Company (2020-2025)
3.3 Global Androstenedione Sale Price by Company
3.4 Key Manufacturers Androstenedione Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Androstenedione Product Location Distribution
3.4.2 Players Androstenedione Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANDROSTENEDIONE BY GEOGRAPHIC REGION
4.1 World Historic Androstenedione Market Size by Geographic Region (2020-2025)
4.1.1 Global Androstenedione Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Androstenedione Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Androstenedione Market Size by Country/Region (2020-2025)
4.2.1 Global Androstenedione Annual Sales by Country/Region (2020-2025)
4.2.2 Global Androstenedione Annual Revenue by Country/Region (2020-2025)
4.3 Americas Androstenedione Sales Growth
4.4 APAC Androstenedione Sales Growth
4.5 Europe Androstenedione Sales Growth
4.6 Middle East & Africa Androstenedione Sales Growth
5 AMERICAS
5.1 Americas Androstenedione Sales by Country
5.1.1 Americas Androstenedione Sales by Country (2020-2025)
5.1.2 Americas Androstenedione Revenue by Country (2020-2025)
5.2 Americas Androstenedione Sales by Type (2020-2025)
5.3 Americas Androstenedione Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Androstenedione Sales by Region
6.1.1 APAC Androstenedione Sales by Region (2020-2025)
6.1.2 APAC Androstenedione Revenue by Region (2020-2025)
6.2 APAC Androstenedione Sales by Type (2020-2025)
6.3 APAC Androstenedione Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Androstenedione by Country
7.1.1 Europe Androstenedione Sales by Country (2020-2025)
7.1.2 Europe Androstenedione Revenue by Country (2020-2025)
7.2 Europe Androstenedione Sales by Type (2020-2025)
7.3 Europe Androstenedione Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Androstenedione by Country
8.1.1 Middle East & Africa Androstenedione Sales by Country (2020-2025)
8.1.2 Middle East & Africa Androstenedione Revenue by Country (2020-2025)
8.2 Middle East & Africa Androstenedione Sales by Type (2020-2025)
8.3 Middle East & Africa Androstenedione Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Androstenedione
10.3 Manufacturing Process Analysis of Androstenedione
10.4 Industry Chain Structure of Androstenedione
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Androstenedione Distributors
11.3 Androstenedione Customer
12 WORLD FORECAST REVIEW FOR ANDROSTENEDIONE BY GEOGRAPHIC REGION
12.1 Global Androstenedione Market Size Forecast by Region
12.1.1 Global Androstenedione Forecast by Region (2026-2031)
12.1.2 Global Androstenedione Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Androstenedione Forecast by Type (2026-2031)
12.7 Global Androstenedione Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 BIOVET
13.1.1 BIOVET Company Information
13.1.2 BIOVET Androstenedione Product Portfolios and Specifications
13.1.3 BIOVET Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BIOVET Main Business Overview
13.1.5 BIOVET Latest Developments
13.2 Indo Phyto Chemicals
13.2.1 Indo Phyto Chemicals Company Information
13.2.2 Indo Phyto Chemicals Androstenedione Product Portfolios and Specifications
13.2.3 Indo Phyto Chemicals Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Indo Phyto Chemicals Main Business Overview
13.2.5 Indo Phyto Chemicals Latest Developments
13.3 Sito Bio
13.3.1 Sito Bio Company Information
13.3.2 Sito Bio Androstenedione Product Portfolios and Specifications
13.3.3 Sito Bio Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sito Bio Main Business Overview
13.3.5 Sito Bio Latest Developments
13.4 Goto Pharmaceutical
13.4.1 Goto Pharmaceutical Company Information
13.4.2 Goto Pharmaceutical Androstenedione Product Portfolios and Specifications
13.4.3 Goto Pharmaceutical Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Goto Pharmaceutical Main Business Overview
13.4.5 Goto Pharmaceutical Latest Developments
13.5 Tianjin King York
13.5.1 Tianjin King York Company Information
13.5.2 Tianjin King York Androstenedione Product Portfolios and Specifications
13.5.3 Tianjin King York Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Tianjin King York Main Business Overview
13.5.5 Tianjin King York Latest Developments
13.6 Jiufu
13.6.1 Jiufu Company Information
13.6.2 Jiufu Androstenedione Product Portfolios and Specifications
13.6.3 Jiufu Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Jiufu Main Business Overview
13.6.5 Jiufu Latest Developments
13.7 Yongning Pharma
13.7.1 Yongning Pharma Company Information
13.7.2 Yongning Pharma Androstenedione Product Portfolios and Specifications
13.7.3 Yongning Pharma Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Yongning Pharma Main Business Overview
13.7.5 Yongning Pharma Latest Developments
13.8 Jiangxi Hongyuan Pharmaceutical
13.8.1 Jiangxi Hongyuan Pharmaceutical Company Information
13.8.2 Jiangxi Hongyuan Pharmaceutical Androstenedione Product Portfolios and Specifications
13.8.3 Jiangxi Hongyuan Pharmaceutical Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Jiangxi Hongyuan Pharmaceutical Main Business Overview
13.8.5 Jiangxi Hongyuan Pharmaceutical Latest Developments
13.9 Kaizon
13.9.1 Kaizon Company Information
13.9.2 Kaizon Androstenedione Product Portfolios and Specifications
13.9.3 Kaizon Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Kaizon Main Business Overview
13.9.5 Kaizon Latest Developments
13.10 Xi’an Gaoyuan Bio-Chem
13.10.1 Xi’an Gaoyuan Bio-Chem Company Information
13.10.2 Xi’an Gaoyuan Bio-Chem Androstenedione Product Portfolios and Specifications
13.10.3 Xi’an Gaoyuan Bio-Chem Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Xi’an Gaoyuan Bio-Chem Main Business Overview
13.10.5 Xi’an Gaoyuan Bio-Chem Latest Developments
13.11 Dongyao Pharmaceutical
13.11.1 Dongyao Pharmaceutical Company Information
13.11.2 Dongyao Pharmaceutical Androstenedione Product Portfolios and Specifications
13.11.3 Dongyao Pharmaceutical Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Dongyao Pharmaceutical Main Business Overview
13.11.5 Dongyao Pharmaceutical Latest Developments
13.12 Huazhong Pharmaceutical
13.12.1 Huazhong Pharmaceutical Company Information
13.12.2 Huazhong Pharmaceutical Androstenedione Product Portfolios and Specifications
13.12.3 Huazhong Pharmaceutical Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Huazhong Pharmaceutical Main Business Overview
13.12.5 Huazhong Pharmaceutical Latest Developments
13.13 Darui
13.13.1 Darui Company Information
13.13.2 Darui Androstenedione Product Portfolios and Specifications
13.13.3 Darui Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Darui Main Business Overview
13.13.5 Darui Latest Developments
13.14 Danjiangkou Danao
13.14.1 Danjiangkou Danao Company Information
13.14.2 Danjiangkou Danao Androstenedione Product Portfolios and Specifications
13.14.3 Danjiangkou Danao Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Danjiangkou Danao Main Business Overview
13.14.5 Danjiangkou Danao Latest Developments
13.15 Dahua Pharmaceutical
13.15.1 Dahua Pharmaceutical Company Information
13.15.2 Dahua Pharmaceutical Androstenedione Product Portfolios and Specifications
13.15.3 Dahua Pharmaceutical Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Dahua Pharmaceutical Main Business Overview
13.15.5 Dahua Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Androstenedione Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Androstenedione Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Androstenedione
Table 4. Major Players of Androstadienedione
Table 5. Global Androstenedione Sales byType (2020-2025) & (K Units)
Table 6. Global Androstenedione Sales Market Share byType (2020-2025)
Table 7. Global Androstenedione Revenue byType (2020-2025) & ($ million)
Table 8. Global Androstenedione Revenue Market Share byType (2020-2025)
Table 9. Global Androstenedione Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global Androstenedione Sale by Application (2020-2025) & (K Units)
Table 11. Global Androstenedione Sale Market Share by Application (2020-2025)
Table 12. Global Androstenedione Revenue by Application (2020-2025) & ($ million)
Table 13. Global Androstenedione Revenue Market Share by Application (2020-2025)
Table 14. Global Androstenedione Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Androstenedione Sales by Company (2020-2025) & (K Units)
Table 16. Global Androstenedione Sales Market Share by Company (2020-2025)
Table 17. Global Androstenedione Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Androstenedione Revenue Market Share by Company (2020-2025)
Table 19. Global Androstenedione Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Androstenedione Producing Area Distribution and Sales Area
Table 21. Players Androstenedione Products Offered
Table 22. Androstenedione Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Androstenedione Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Androstenedione Sales Market Share Geographic Region (2020-2025)
Table 27. Global Androstenedione Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Androstenedione Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Androstenedione Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Androstenedione Sales Market Share by Country/Region (2020-2025)
Table 31. Global Androstenedione Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Androstenedione Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Androstenedione Sales by Country (2020-2025) & (K Units)
Table 34. Americas Androstenedione Sales Market Share by Country (2020-2025)
Table 35. Americas Androstenedione Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Androstenedione Sales byType (2020-2025) & (K Units)
Table 37. Americas Androstenedione Sales by Application (2020-2025) & (K Units)
Table 38. APAC Androstenedione Sales by Region (2020-2025) & (K Units)
Table 39. APAC Androstenedione Sales Market Share by Region (2020-2025)
Table 40. APAC Androstenedione Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Androstenedione Sales byType (2020-2025) & (K Units)
Table 42. APAC Androstenedione Sales by Application (2020-2025) & (K Units)
Table 43. Europe Androstenedione Sales by Country (2020-2025) & (K Units)
Table 44. Europe Androstenedione Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Androstenedione Sales byType (2020-2025) & (K Units)
Table 46. Europe Androstenedione Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Androstenedione Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Androstenedione Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Androstenedione Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Androstenedione Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Androstenedione
Table 52. Key Market Challenges & Risks of Androstenedione
Table 53. Key IndustryTrends of Androstenedione
Table 54. Androstenedione Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Androstenedione Distributors List
Table 57. Androstenedione Customer List
Table 58. Global Androstenedione SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Androstenedione RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Androstenedione SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Androstenedione Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Androstenedione SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Androstenedione Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Androstenedione SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Androstenedione RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Androstenedione SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Androstenedione RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Androstenedione SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Androstenedione RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Androstenedione SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Androstenedione RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. BIOVET Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 73. BIOVET Androstenedione Product Portfolios and Specifications
Table 74. BIOVET Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. BIOVET Main Business
Table 76. BIOVET Latest Developments
Table 77. Indo Phyto Chemicals Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 78. Indo Phyto Chemicals Androstenedione Product Portfolios and Specifications
Table 79. Indo Phyto Chemicals Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Indo Phyto Chemicals Main Business
Table 81. Indo Phyto Chemicals Latest Developments
Table 82. Sito Bio Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 83. Sito Bio Androstenedione Product Portfolios and Specifications
Table 84. Sito Bio Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Sito Bio Main Business
Table 86. Sito Bio Latest Developments
Table 87. Goto Pharmaceutical Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 88. Goto Pharmaceutical Androstenedione Product Portfolios and Specifications
Table 89. Goto Pharmaceutical Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Goto Pharmaceutical Main Business
Table 91. Goto Pharmaceutical Latest Developments
Table 92.Tianjin King York Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 93.Tianjin King York Androstenedione Product Portfolios and Specifications
Table 94.Tianjin King York Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95.Tianjin King York Main Business
Table 96.Tianjin King York Latest Developments
Table 97. Jiufu Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 98. Jiufu Androstenedione Product Portfolios and Specifications
Table 99. Jiufu Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Jiufu Main Business
Table 101. Jiufu Latest Developments
Table 102. Yongning Pharma Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 103. Yongning Pharma Androstenedione Product Portfolios and Specifications
Table 104. Yongning Pharma Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Yongning Pharma Main Business
Table 106. Yongning Pharma Latest Developments
Table 107. Jiangxi Hongyuan Pharmaceutical Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 108. Jiangxi Hongyuan Pharmaceutical Androstenedione Product Portfolios and Specifications
Table 109. Jiangxi Hongyuan Pharmaceutical Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Jiangxi Hongyuan Pharmaceutical Main Business
Table 111. Jiangxi Hongyuan Pharmaceutical Latest Developments
Table 112. Kaizon Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 113. Kaizon Androstenedione Product Portfolios and Specifications
Table 114. Kaizon Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Kaizon Main Business
Table 116. Kaizon Latest Developments
Table 117. Xi’an Gaoyuan Bio-Chem Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 118. Xi’an Gaoyuan Bio-Chem Androstenedione Product Portfolios and Specifications
Table 119. Xi’an Gaoyuan Bio-Chem Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Xi’an Gaoyuan Bio-Chem Main Business
Table 121. Xi’an Gaoyuan Bio-Chem Latest Developments
Table 122. Dongyao Pharmaceutical Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 123. Dongyao Pharmaceutical Androstenedione Product Portfolios and Specifications
Table 124. Dongyao Pharmaceutical Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Dongyao Pharmaceutical Main Business
Table 126. Dongyao Pharmaceutical Latest Developments
Table 127. Huazhong Pharmaceutical Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 128. Huazhong Pharmaceutical Androstenedione Product Portfolios and Specifications
Table 129. Huazhong Pharmaceutical Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Huazhong Pharmaceutical Main Business
Table 131. Huazhong Pharmaceutical Latest Developments
Table 132. Darui Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 133. Darui Androstenedione Product Portfolios and Specifications
Table 134. Darui Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Darui Main Business
Table 136. Darui Latest Developments
Table 137. Danjiangkou Danao Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 138. Danjiangkou Danao Androstenedione Product Portfolios and Specifications
Table 139. Danjiangkou Danao Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Danjiangkou Danao Main Business
Table 141. Danjiangkou Danao Latest Developments
Table 142. Dahua Pharmaceutical Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 143. Dahua Pharmaceutical Androstenedione Product Portfolios and Specifications
Table 144. Dahua Pharmaceutical Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. Dahua Pharmaceutical Main Business
Table 146. Dahua Pharmaceutical Latest Developments
LIST OFFIGURES
Figure 1. Picture of Androstenedione
Figure 2. Androstenedione Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Androstenedione Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Androstenedione Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Androstenedione Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Androstenedione Sales Market Share by Country/Region (2024)
Figure 10. Androstenedione Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Androstenedione
Figure 12. Product Picture of Androstadienedione
Figure 13. Global Androstenedione Sales Market Share byType in 2025
Figure 14. Global Androstenedione Revenue Market Share byType (2020-2025)
Figure 15. Androstenedione Consumed in Arthritis Pharmaceuticals
Figure 16. Global Androstenedione Market: Arthritis Pharmaceuticals (2020-2025) & (K Units)
Figure 17. Androstenedione Consumed inFertility Control Pharmaceuticals
Figure 18. Global Androstenedione Market:Fertility Control Pharmaceuticals (2020-2025) & (K Units)
Figure 19. Androstenedione Consumed in Infectious Inflammation Pharmaceuticals
Figure 20. Global Androstenedione Market: Infectious Inflammation Pharmaceuticals (2020-2025) & (K Units)
Figure 21. Androstenedione Consumed in Others
Figure 22. Global Androstenedione Market: Others (2020-2025) & (K Units)
Figure 23. Global Androstenedione Sale Market Share by Application (2024)
Figure 24. Global Androstenedione Revenue Market Share by Application in 2025
Figure 25. Androstenedione Sales by Company in 2025 (K Units)
Figure 26. Global Androstenedione Sales Market Share by Company in 2025
Figure 27. Androstenedione Revenue by Company in 2025 ($ millions)
Figure 28. Global Androstenedione Revenue Market Share by Company in 2025
Figure 29. Global Androstenedione Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Androstenedione Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Androstenedione Sales 2020-2025 (K Units)
Figure 32. Americas Androstenedione Revenue 2020-2025 ($ millions)
Figure 33. APAC Androstenedione Sales 2020-2025 (K Units)
Figure 34. APAC Androstenedione Revenue 2020-2025 ($ millions)
Figure 35. Europe Androstenedione Sales 2020-2025 (K Units)
Figure 36. Europe Androstenedione Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Androstenedione Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Androstenedione Revenue 2020-2025 ($ millions)
Figure 39. Americas Androstenedione Sales Market Share by Country in 2025
Figure 40. Americas Androstenedione Revenue Market Share by Country (2020-2025)
Figure 41. Americas Androstenedione Sales Market Share byType (2020-2025)
Figure 42. Americas Androstenedione Sales Market Share by Application (2020-2025)
Figure 43. United States Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Androstenedione Sales Market Share by Region in 2025
Figure 48. APAC Androstenedione Revenue Market Share by Region (2020-2025)
Figure 49. APAC Androstenedione Sales Market Share byType (2020-2025)
Figure 50. APAC Androstenedione Sales Market Share by Application (2020-2025)
Figure 51. China Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 55. India Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Androstenedione Sales Market Share by Country in 2025
Figure 59. Europe Androstenedione Revenue Market Share by Country (2020-2025)
Figure 60. Europe Androstenedione Sales Market Share byType (2020-2025)
Figure 61. Europe Androstenedione Sales Market Share by Application (2020-2025)
Figure 62. Germany Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 63.France Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Androstenedione Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Androstenedione Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Androstenedione Sales Market Share by Application (2020-2025)
Figure 70. Egypt Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Androstenedione in 2025
Figure 76. Manufacturing Process Analysis of Androstenedione
Figure 77. Industry Chain Structure of Androstenedione
Figure 78. Channels of Distribution
Figure 79. Global Androstenedione Sales MarketForecast by Region (2026-2031)
Figure 80. Global Androstenedione Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Androstenedione Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Androstenedione Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Androstenedione Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Androstenedione Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Androstenedione Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Androstenedione by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Androstenedione by Country/Region, 2020, 2024 & 2031
2.2 Androstenedione Segment by Type
2.2.1 Androstenedione
2.2.2 Androstadienedione
2.3 Androstenedione Sales by Type
2.3.1 Global Androstenedione Sales Market Share by Type (2020-2025)
2.3.2 Global Androstenedione Revenue and Market Share by Type (2020-2025)
2.3.3 Global Androstenedione Sale Price by Type (2020-2025)
2.4 Androstenedione Segment by Application
2.4.1 Arthritis Pharmaceuticals
2.4.2 Fertility Control Pharmaceuticals
2.4.3 Infectious Inflammation Pharmaceuticals
2.4.4 Others
2.5 Androstenedione Sales by Application
2.5.1 Global Androstenedione Sale Market Share by Application (2020-2025)
2.5.2 Global Androstenedione Revenue and Market Share by Application (2020-2025)
2.5.3 Global Androstenedione Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Androstenedione Breakdown Data by Company
3.1.1 Global Androstenedione Annual Sales by Company (2020-2025)
3.1.2 Global Androstenedione Sales Market Share by Company (2020-2025)
3.2 Global Androstenedione Annual Revenue by Company (2020-2025)
3.2.1 Global Androstenedione Revenue by Company (2020-2025)
3.2.2 Global Androstenedione Revenue Market Share by Company (2020-2025)
3.3 Global Androstenedione Sale Price by Company
3.4 Key Manufacturers Androstenedione Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Androstenedione Product Location Distribution
3.4.2 Players Androstenedione Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANDROSTENEDIONE BY GEOGRAPHIC REGION
4.1 World Historic Androstenedione Market Size by Geographic Region (2020-2025)
4.1.1 Global Androstenedione Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Androstenedione Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Androstenedione Market Size by Country/Region (2020-2025)
4.2.1 Global Androstenedione Annual Sales by Country/Region (2020-2025)
4.2.2 Global Androstenedione Annual Revenue by Country/Region (2020-2025)
4.3 Americas Androstenedione Sales Growth
4.4 APAC Androstenedione Sales Growth
4.5 Europe Androstenedione Sales Growth
4.6 Middle East & Africa Androstenedione Sales Growth
5 AMERICAS
5.1 Americas Androstenedione Sales by Country
5.1.1 Americas Androstenedione Sales by Country (2020-2025)
5.1.2 Americas Androstenedione Revenue by Country (2020-2025)
5.2 Americas Androstenedione Sales by Type (2020-2025)
5.3 Americas Androstenedione Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Androstenedione Sales by Region
6.1.1 APAC Androstenedione Sales by Region (2020-2025)
6.1.2 APAC Androstenedione Revenue by Region (2020-2025)
6.2 APAC Androstenedione Sales by Type (2020-2025)
6.3 APAC Androstenedione Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Androstenedione by Country
7.1.1 Europe Androstenedione Sales by Country (2020-2025)
7.1.2 Europe Androstenedione Revenue by Country (2020-2025)
7.2 Europe Androstenedione Sales by Type (2020-2025)
7.3 Europe Androstenedione Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Androstenedione by Country
8.1.1 Middle East & Africa Androstenedione Sales by Country (2020-2025)
8.1.2 Middle East & Africa Androstenedione Revenue by Country (2020-2025)
8.2 Middle East & Africa Androstenedione Sales by Type (2020-2025)
8.3 Middle East & Africa Androstenedione Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Androstenedione
10.3 Manufacturing Process Analysis of Androstenedione
10.4 Industry Chain Structure of Androstenedione
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Androstenedione Distributors
11.3 Androstenedione Customer
12 WORLD FORECAST REVIEW FOR ANDROSTENEDIONE BY GEOGRAPHIC REGION
12.1 Global Androstenedione Market Size Forecast by Region
12.1.1 Global Androstenedione Forecast by Region (2026-2031)
12.1.2 Global Androstenedione Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Androstenedione Forecast by Type (2026-2031)
12.7 Global Androstenedione Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 BIOVET
13.1.1 BIOVET Company Information
13.1.2 BIOVET Androstenedione Product Portfolios and Specifications
13.1.3 BIOVET Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BIOVET Main Business Overview
13.1.5 BIOVET Latest Developments
13.2 Indo Phyto Chemicals
13.2.1 Indo Phyto Chemicals Company Information
13.2.2 Indo Phyto Chemicals Androstenedione Product Portfolios and Specifications
13.2.3 Indo Phyto Chemicals Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Indo Phyto Chemicals Main Business Overview
13.2.5 Indo Phyto Chemicals Latest Developments
13.3 Sito Bio
13.3.1 Sito Bio Company Information
13.3.2 Sito Bio Androstenedione Product Portfolios and Specifications
13.3.3 Sito Bio Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sito Bio Main Business Overview
13.3.5 Sito Bio Latest Developments
13.4 Goto Pharmaceutical
13.4.1 Goto Pharmaceutical Company Information
13.4.2 Goto Pharmaceutical Androstenedione Product Portfolios and Specifications
13.4.3 Goto Pharmaceutical Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Goto Pharmaceutical Main Business Overview
13.4.5 Goto Pharmaceutical Latest Developments
13.5 Tianjin King York
13.5.1 Tianjin King York Company Information
13.5.2 Tianjin King York Androstenedione Product Portfolios and Specifications
13.5.3 Tianjin King York Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Tianjin King York Main Business Overview
13.5.5 Tianjin King York Latest Developments
13.6 Jiufu
13.6.1 Jiufu Company Information
13.6.2 Jiufu Androstenedione Product Portfolios and Specifications
13.6.3 Jiufu Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Jiufu Main Business Overview
13.6.5 Jiufu Latest Developments
13.7 Yongning Pharma
13.7.1 Yongning Pharma Company Information
13.7.2 Yongning Pharma Androstenedione Product Portfolios and Specifications
13.7.3 Yongning Pharma Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Yongning Pharma Main Business Overview
13.7.5 Yongning Pharma Latest Developments
13.8 Jiangxi Hongyuan Pharmaceutical
13.8.1 Jiangxi Hongyuan Pharmaceutical Company Information
13.8.2 Jiangxi Hongyuan Pharmaceutical Androstenedione Product Portfolios and Specifications
13.8.3 Jiangxi Hongyuan Pharmaceutical Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Jiangxi Hongyuan Pharmaceutical Main Business Overview
13.8.5 Jiangxi Hongyuan Pharmaceutical Latest Developments
13.9 Kaizon
13.9.1 Kaizon Company Information
13.9.2 Kaizon Androstenedione Product Portfolios and Specifications
13.9.3 Kaizon Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Kaizon Main Business Overview
13.9.5 Kaizon Latest Developments
13.10 Xi’an Gaoyuan Bio-Chem
13.10.1 Xi’an Gaoyuan Bio-Chem Company Information
13.10.2 Xi’an Gaoyuan Bio-Chem Androstenedione Product Portfolios and Specifications
13.10.3 Xi’an Gaoyuan Bio-Chem Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Xi’an Gaoyuan Bio-Chem Main Business Overview
13.10.5 Xi’an Gaoyuan Bio-Chem Latest Developments
13.11 Dongyao Pharmaceutical
13.11.1 Dongyao Pharmaceutical Company Information
13.11.2 Dongyao Pharmaceutical Androstenedione Product Portfolios and Specifications
13.11.3 Dongyao Pharmaceutical Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Dongyao Pharmaceutical Main Business Overview
13.11.5 Dongyao Pharmaceutical Latest Developments
13.12 Huazhong Pharmaceutical
13.12.1 Huazhong Pharmaceutical Company Information
13.12.2 Huazhong Pharmaceutical Androstenedione Product Portfolios and Specifications
13.12.3 Huazhong Pharmaceutical Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Huazhong Pharmaceutical Main Business Overview
13.12.5 Huazhong Pharmaceutical Latest Developments
13.13 Darui
13.13.1 Darui Company Information
13.13.2 Darui Androstenedione Product Portfolios and Specifications
13.13.3 Darui Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Darui Main Business Overview
13.13.5 Darui Latest Developments
13.14 Danjiangkou Danao
13.14.1 Danjiangkou Danao Company Information
13.14.2 Danjiangkou Danao Androstenedione Product Portfolios and Specifications
13.14.3 Danjiangkou Danao Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Danjiangkou Danao Main Business Overview
13.14.5 Danjiangkou Danao Latest Developments
13.15 Dahua Pharmaceutical
13.15.1 Dahua Pharmaceutical Company Information
13.15.2 Dahua Pharmaceutical Androstenedione Product Portfolios and Specifications
13.15.3 Dahua Pharmaceutical Androstenedione Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Dahua Pharmaceutical Main Business Overview
13.15.5 Dahua Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Androstenedione Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Androstenedione Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Androstenedione
Table 4. Major Players of Androstadienedione
Table 5. Global Androstenedione Sales byType (2020-2025) & (K Units)
Table 6. Global Androstenedione Sales Market Share byType (2020-2025)
Table 7. Global Androstenedione Revenue byType (2020-2025) & ($ million)
Table 8. Global Androstenedione Revenue Market Share byType (2020-2025)
Table 9. Global Androstenedione Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global Androstenedione Sale by Application (2020-2025) & (K Units)
Table 11. Global Androstenedione Sale Market Share by Application (2020-2025)
Table 12. Global Androstenedione Revenue by Application (2020-2025) & ($ million)
Table 13. Global Androstenedione Revenue Market Share by Application (2020-2025)
Table 14. Global Androstenedione Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Androstenedione Sales by Company (2020-2025) & (K Units)
Table 16. Global Androstenedione Sales Market Share by Company (2020-2025)
Table 17. Global Androstenedione Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Androstenedione Revenue Market Share by Company (2020-2025)
Table 19. Global Androstenedione Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Androstenedione Producing Area Distribution and Sales Area
Table 21. Players Androstenedione Products Offered
Table 22. Androstenedione Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Androstenedione Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Androstenedione Sales Market Share Geographic Region (2020-2025)
Table 27. Global Androstenedione Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Androstenedione Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Androstenedione Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Androstenedione Sales Market Share by Country/Region (2020-2025)
Table 31. Global Androstenedione Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Androstenedione Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Androstenedione Sales by Country (2020-2025) & (K Units)
Table 34. Americas Androstenedione Sales Market Share by Country (2020-2025)
Table 35. Americas Androstenedione Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Androstenedione Sales byType (2020-2025) & (K Units)
Table 37. Americas Androstenedione Sales by Application (2020-2025) & (K Units)
Table 38. APAC Androstenedione Sales by Region (2020-2025) & (K Units)
Table 39. APAC Androstenedione Sales Market Share by Region (2020-2025)
Table 40. APAC Androstenedione Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Androstenedione Sales byType (2020-2025) & (K Units)
Table 42. APAC Androstenedione Sales by Application (2020-2025) & (K Units)
Table 43. Europe Androstenedione Sales by Country (2020-2025) & (K Units)
Table 44. Europe Androstenedione Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Androstenedione Sales byType (2020-2025) & (K Units)
Table 46. Europe Androstenedione Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Androstenedione Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Androstenedione Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Androstenedione Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Androstenedione Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Androstenedione
Table 52. Key Market Challenges & Risks of Androstenedione
Table 53. Key IndustryTrends of Androstenedione
Table 54. Androstenedione Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Androstenedione Distributors List
Table 57. Androstenedione Customer List
Table 58. Global Androstenedione SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Androstenedione RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Androstenedione SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Androstenedione Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Androstenedione SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Androstenedione Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Androstenedione SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Androstenedione RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Androstenedione SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Androstenedione RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Androstenedione SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Androstenedione RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Androstenedione SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Androstenedione RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. BIOVET Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 73. BIOVET Androstenedione Product Portfolios and Specifications
Table 74. BIOVET Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. BIOVET Main Business
Table 76. BIOVET Latest Developments
Table 77. Indo Phyto Chemicals Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 78. Indo Phyto Chemicals Androstenedione Product Portfolios and Specifications
Table 79. Indo Phyto Chemicals Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Indo Phyto Chemicals Main Business
Table 81. Indo Phyto Chemicals Latest Developments
Table 82. Sito Bio Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 83. Sito Bio Androstenedione Product Portfolios and Specifications
Table 84. Sito Bio Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Sito Bio Main Business
Table 86. Sito Bio Latest Developments
Table 87. Goto Pharmaceutical Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 88. Goto Pharmaceutical Androstenedione Product Portfolios and Specifications
Table 89. Goto Pharmaceutical Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Goto Pharmaceutical Main Business
Table 91. Goto Pharmaceutical Latest Developments
Table 92.Tianjin King York Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 93.Tianjin King York Androstenedione Product Portfolios and Specifications
Table 94.Tianjin King York Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95.Tianjin King York Main Business
Table 96.Tianjin King York Latest Developments
Table 97. Jiufu Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 98. Jiufu Androstenedione Product Portfolios and Specifications
Table 99. Jiufu Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Jiufu Main Business
Table 101. Jiufu Latest Developments
Table 102. Yongning Pharma Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 103. Yongning Pharma Androstenedione Product Portfolios and Specifications
Table 104. Yongning Pharma Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Yongning Pharma Main Business
Table 106. Yongning Pharma Latest Developments
Table 107. Jiangxi Hongyuan Pharmaceutical Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 108. Jiangxi Hongyuan Pharmaceutical Androstenedione Product Portfolios and Specifications
Table 109. Jiangxi Hongyuan Pharmaceutical Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Jiangxi Hongyuan Pharmaceutical Main Business
Table 111. Jiangxi Hongyuan Pharmaceutical Latest Developments
Table 112. Kaizon Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 113. Kaizon Androstenedione Product Portfolios and Specifications
Table 114. Kaizon Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Kaizon Main Business
Table 116. Kaizon Latest Developments
Table 117. Xi’an Gaoyuan Bio-Chem Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 118. Xi’an Gaoyuan Bio-Chem Androstenedione Product Portfolios and Specifications
Table 119. Xi’an Gaoyuan Bio-Chem Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Xi’an Gaoyuan Bio-Chem Main Business
Table 121. Xi’an Gaoyuan Bio-Chem Latest Developments
Table 122. Dongyao Pharmaceutical Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 123. Dongyao Pharmaceutical Androstenedione Product Portfolios and Specifications
Table 124. Dongyao Pharmaceutical Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Dongyao Pharmaceutical Main Business
Table 126. Dongyao Pharmaceutical Latest Developments
Table 127. Huazhong Pharmaceutical Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 128. Huazhong Pharmaceutical Androstenedione Product Portfolios and Specifications
Table 129. Huazhong Pharmaceutical Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Huazhong Pharmaceutical Main Business
Table 131. Huazhong Pharmaceutical Latest Developments
Table 132. Darui Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 133. Darui Androstenedione Product Portfolios and Specifications
Table 134. Darui Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Darui Main Business
Table 136. Darui Latest Developments
Table 137. Danjiangkou Danao Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 138. Danjiangkou Danao Androstenedione Product Portfolios and Specifications
Table 139. Danjiangkou Danao Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Danjiangkou Danao Main Business
Table 141. Danjiangkou Danao Latest Developments
Table 142. Dahua Pharmaceutical Basic Information, Androstenedione Manufacturing Base, Sales Area and Its Competitors
Table 143. Dahua Pharmaceutical Androstenedione Product Portfolios and Specifications
Table 144. Dahua Pharmaceutical Androstenedione Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. Dahua Pharmaceutical Main Business
Table 146. Dahua Pharmaceutical Latest Developments
LIST OFFIGURES
Figure 1. Picture of Androstenedione
Figure 2. Androstenedione Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Androstenedione Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Androstenedione Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Androstenedione Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Androstenedione Sales Market Share by Country/Region (2024)
Figure 10. Androstenedione Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Androstenedione
Figure 12. Product Picture of Androstadienedione
Figure 13. Global Androstenedione Sales Market Share byType in 2025
Figure 14. Global Androstenedione Revenue Market Share byType (2020-2025)
Figure 15. Androstenedione Consumed in Arthritis Pharmaceuticals
Figure 16. Global Androstenedione Market: Arthritis Pharmaceuticals (2020-2025) & (K Units)
Figure 17. Androstenedione Consumed inFertility Control Pharmaceuticals
Figure 18. Global Androstenedione Market:Fertility Control Pharmaceuticals (2020-2025) & (K Units)
Figure 19. Androstenedione Consumed in Infectious Inflammation Pharmaceuticals
Figure 20. Global Androstenedione Market: Infectious Inflammation Pharmaceuticals (2020-2025) & (K Units)
Figure 21. Androstenedione Consumed in Others
Figure 22. Global Androstenedione Market: Others (2020-2025) & (K Units)
Figure 23. Global Androstenedione Sale Market Share by Application (2024)
Figure 24. Global Androstenedione Revenue Market Share by Application in 2025
Figure 25. Androstenedione Sales by Company in 2025 (K Units)
Figure 26. Global Androstenedione Sales Market Share by Company in 2025
Figure 27. Androstenedione Revenue by Company in 2025 ($ millions)
Figure 28. Global Androstenedione Revenue Market Share by Company in 2025
Figure 29. Global Androstenedione Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Androstenedione Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Androstenedione Sales 2020-2025 (K Units)
Figure 32. Americas Androstenedione Revenue 2020-2025 ($ millions)
Figure 33. APAC Androstenedione Sales 2020-2025 (K Units)
Figure 34. APAC Androstenedione Revenue 2020-2025 ($ millions)
Figure 35. Europe Androstenedione Sales 2020-2025 (K Units)
Figure 36. Europe Androstenedione Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Androstenedione Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Androstenedione Revenue 2020-2025 ($ millions)
Figure 39. Americas Androstenedione Sales Market Share by Country in 2025
Figure 40. Americas Androstenedione Revenue Market Share by Country (2020-2025)
Figure 41. Americas Androstenedione Sales Market Share byType (2020-2025)
Figure 42. Americas Androstenedione Sales Market Share by Application (2020-2025)
Figure 43. United States Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Androstenedione Sales Market Share by Region in 2025
Figure 48. APAC Androstenedione Revenue Market Share by Region (2020-2025)
Figure 49. APAC Androstenedione Sales Market Share byType (2020-2025)
Figure 50. APAC Androstenedione Sales Market Share by Application (2020-2025)
Figure 51. China Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 55. India Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Androstenedione Sales Market Share by Country in 2025
Figure 59. Europe Androstenedione Revenue Market Share by Country (2020-2025)
Figure 60. Europe Androstenedione Sales Market Share byType (2020-2025)
Figure 61. Europe Androstenedione Sales Market Share by Application (2020-2025)
Figure 62. Germany Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 63.France Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Androstenedione Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Androstenedione Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Androstenedione Sales Market Share by Application (2020-2025)
Figure 70. Egypt Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Androstenedione Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Androstenedione in 2025
Figure 76. Manufacturing Process Analysis of Androstenedione
Figure 77. Industry Chain Structure of Androstenedione
Figure 78. Channels of Distribution
Figure 79. Global Androstenedione Sales MarketForecast by Region (2026-2031)
Figure 80. Global Androstenedione Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Androstenedione Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Androstenedione Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Androstenedione Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Androstenedione Revenue Market ShareForecast by Application (2026-2031)
